Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
1MED Logo
1MED Growth Score
81
CB Rank
584186
Heat Score
44
1MED is a full service CRO offering clinical research services and solutions for all clinical trials' needs.
Acquired by
Apposite Capital Logo
Apposite Capital
Founded
obfuscation
Private Agno, Ticino, Switzerland11-50 www.1med.ch/
Biotechnology
Overview

1MED
Growth Score
81
Heat Score
44

Growth Score81
-6 pts
in past quarter
Heat Score 44
9 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
See more interactive data and historical milestones on desktop for the best experience

About 1MED

CB Rank
584186
1MED is a full service CRO offering clinical research services and solutions for all clinical trials' needs.
Acquired by
Apposite Capital Logo
Apposite Capital
Founded
obfuscation
Private Agno, Ticino, Switzerland11-50 www.1med.ch/
Biotechnology

Details

Operating Status Active
Company Type For Profit
About the Company
1MED is a full service CRO offering clinical research services and solutions for all clinical trials' needs.
Phone Number +41 (0)91 605 40 50
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

Clinical Research Services
Provides management and operational support for clinical trials across phases I-IV for medical devices, pharmaceuticals, and biotech products.
Regulatory Affairs and Compliance Support
Assists medical device and pharmaceutical companies in navigating regulatory requirements and submissions for product approval and compliance.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

M&A Details

1MED was bought out by Apposite Capital on
obfuscation
.
Transaction Name 
1MED acquired by Apposite Capital Logo
1MED acquired by Apposite Capital
Acquired by 
Apposite Capital Logo
Apposite Capital
Announced Date 
obfuscation
Market Intelligence
People
View Profiles & Contacts
Headcount 11-50 Contacts 16
News

News and Press

News•Jan 22, 2024
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jun 4, 2021
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

IT Spend

$242.6KThis year, 1MED is projected to spend $242.6K on IT, according to Aberdeen.

Active Website Tech Count

21MED is actively using 2 technologies for its website, according to BuiltWith. These include CommonCrawl Top 10m.

Total IP

71MED has registered 7 trademarks with the most popular class being 'Scientific and technological services', according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is 1MED's headquarters? 1MED is located in Agno, Ticino, Switzerland.Who are 1MED's competitors? Alternatives and possible competitors to 1MED may include KCRI, QualityCert, and  be-on-Quality.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(be4ac66 1)
|